CELESTICA INC (CLS.CA) Fundamental Analysis & Valuation

TSX:CLSCA15101Q2071

Current stock price

537.48 CAD
-12.29 (-2.24%)
Last:

This CLS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CLS.CA Profitability Analysis

1.1 Basic Checks

  • CLS had positive earnings in the past year.
  • In the past year CLS had a positive cash flow from operations.
  • In the past 5 years CLS has always been profitable.
  • CLS had a positive operating cash flow in each of the past 5 years.
CLS.CA Yearly Net Income VS EBIT VS OCF VS FCFCLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS's Return On Assets of 11.54% is amongst the best of the industry. CLS outperforms 100.00% of its industry peers.
  • The Return On Equity of CLS (37.56%) is better than 100.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 24.36%, CLS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLS is significantly above the industry average of 8.98%.
  • The 3 year average ROIC (17.88%) for CLS is below the current ROIC(24.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
CLS.CA Yearly ROA, ROE, ROICCLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.72%, CLS is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • CLS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CLS (7.80%) is better than 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of CLS has grown nicely.
  • CLS has a Gross Margin of 12.06%. This is amonst the worse of the industry: CLS underperforms 81.25% of its industry peers.
  • In the last couple of years the Gross Margin of CLS has grown nicely.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS.CA Yearly Profit, Operating, Gross MarginsCLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

8

2. CLS.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
  • CLS has less shares outstanding than it did 1 year ago.
  • CLS has less shares outstanding than it did 5 years ago.
  • CLS has a better debt/assets ratio than last year.
CLS.CA Yearly Shares OutstandingCLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CLS.CA Yearly Total Debt VS Total AssetsCLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • CLS has an Altman-Z score of 7.96. This indicates that CLS is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 7.96, CLS is doing good in the industry, outperforming 62.50% of the companies in the same industry.
  • CLS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • CLS has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. CLS outperforms 93.75% of its industry peers.
  • CLS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • CLS has a Debt to Equity ratio (0.34) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z 7.96
ROIC/WACC2.69
WACC9.06%
CLS.CA Yearly LT Debt VS Equity VS FCFCLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that CLS should not have too much problems paying its short term obligations.
  • CLS has a Current ratio (1.44) which is in line with its industry peers.
  • CLS has a Quick Ratio of 1.44. This is a bad value and indicates that CLS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLS's Quick ratio of 0.88 is in line compared to the rest of the industry. CLS outperforms 43.75% of its industry peers.
  • CLS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS.CA Yearly Current Assets VS Current LiabilitesCLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. CLS.CA Growth Analysis

3.1 Past

  • CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.59%, which is quite impressive.
  • Measured over the past years, CLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.67% on average per year.
  • The Revenue has grown by 28.46% in the past year. This is a very strong growth!
  • Measured over the past years, CLS shows a quite strong growth in Revenue. The Revenue has been growing by 16.61% on average per year.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • Based on estimates for the next years, CLS will show a very strong growth in Earnings Per Share. The EPS will grow by 40.90% on average per year.
  • The Revenue is expected to grow by 36.47% on average over the next years. This is a very strong growth
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue Next Year42.22%
Revenue Next 2Y41.08%
Revenue Next 3Y36.47%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLS.CA Yearly Revenue VS EstimatesCLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CLS.CA Yearly EPS VS EstimatesCLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

6

4. CLS.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CLS is valuated quite expensively with a Price/Earnings ratio of 64.91.
  • CLS's Price/Earnings ratio is rather cheap when compared to the industry. CLS is cheaper than 87.50% of the companies in the same industry.
  • CLS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.47.
  • CLS is valuated quite expensively with a Price/Forward Earnings ratio of 43.68.
  • CLS's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLS is cheaper than 87.50% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.62. CLS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 64.91
Fwd PE 43.68
CLS.CA Price Earnings VS Forward Price EarningsCLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • CLS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLS is cheaper than 87.50% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLS indicates a rather cheap valuation: CLS is cheaper than 81.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 98.63
EV/EBITDA 39.75
CLS.CA Per share dataCLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has an outstanding profitability rating, which may justify a higher PE ratio.
  • CLS's earnings are expected to grow with 40.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.34
PEG (5Y)1.49
EPS Next 2Y46.28%
EPS Next 3Y40.9%

0

5. CLS.CA Dividend Analysis

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

CLS.CA Fundamentals: All Metrics, Ratios and Statistics

CELESTICA INC

TSX:CLS (4/23/2026, 7:00:00 PM)

537.48

-12.29 (-2.24%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-27
Inst Owners72.32%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner ChangeN/A
Market Cap61.79B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts82.35
Price Target370.26 (-31.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)0%
PT rev (3m)6.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.01%
EPS NY rev (1m)0%
EPS NY rev (3m)7.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.4%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)7.3%
Valuation
Industry RankSector Rank
PE 64.91
Fwd PE 43.68
P/S 3.65
P/FCF 98.63
P/OCF 68.54
P/B 20.4
P/tB 27.96
EV/EBITDA 39.75
EPS(TTM)8.28
EY1.54%
EPS(NY)12.31
Fwd EY2.29%
FCF(TTM)5.45
FCFY1.01%
OCF(TTM)7.84
OCFY1.46%
SpS147.33
BVpS26.35
TBVpS19.23
PEG (NY)1.34
PEG (5Y)1.49
Graham Number70.0675 (-86.96%)
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
ROICexc(3y)21.34%
ROICexc(5y)16.25%
ROICexgc(3y)28.33%
ROICexgc(5y)22.11%
ROCE(3y)21.66%
ROCE(5y)16.53%
ROICexgc growth 3Y42.82%
ROICexgc growth 5Y38.52%
ROICexc growth 3Y48.19%
ROICexc growth 5Y40.13%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z 7.96
F-Score7
WACC9.06%
ROIC/WACC2.69
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year42.22%
Revenue Next 2Y41.08%
Revenue Next 3Y36.47%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year74.41%
EBIT Next 3Y58.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 7 / 10 to CLS.CA.


What is the valuation status of CELESTICA INC (CLS.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to CELESTICA INC (CLS.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CELESTICA INC?

CELESTICA INC (CLS.CA) has a profitability rating of 8 / 10.


What is the expected EPS growth for CELESTICA INC (CLS.CA) stock?

The Earnings per Share (EPS) of CELESTICA INC (CLS.CA) is expected to grow by 48.55% in the next year.